Loading…
Akums Drugs and Pharmaceuticals (AKUMS)₹765.85+2.96%Pharmaceuticals
At the end of the Jun 2026 quarter, Akums Drugs and Pharmaceuticals' shareholders were: promoters 75.24%, FIIs 1.92%, DIIs 13.41%, public 6.72%, others 2.71%. Promoter holding is unchanged on the quarter. FII holding is down 2.33 percentage points from 4.25% a year earlier. 0.00% of promoter shares were pledged. It had 70,290 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Promoters | 75.24% | 75.24% | 75.24% | 75.24% | 75.24% | 75.24% | 75.24% | 75.24% |
| FIIs | 7.36% | 6.38% | 5.79% | 4.25% | 2.28% | 1.15% | 1.39% | 1.92% |
| DIIs | 7.50% | 6.96% | 7.36% | 8.82% | 9.25% | 14.38% | 14.33% | 13.41% |
| Public | 7.19% | 8.71% | 8.90% | 8.98% | 10.52% | 6.52% | 6.33% | 6.72% |
| Others | 2.71% | 2.71% | 2.71% | 2.71% | 2.71% | 2.71% | 2.71% | 2.71% |
| Promoter shares pledged | — | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 57,532 | 68,411 | 69,367 | 69,425 | 75,366 | 76,870 | 72,590 | 70,290 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| AKUMS MASTER TRUST (Sanjeev Jain and Sandeep Jain) | Promoter | 40.81% | 0.00 |
| Sandeep Jain | Promoter | 17.27% | 0.00 |
| Sanjeev Jain | Promoter | 17.25% | 0.00 |
| Franklin India Opportunites Fund | DII | 4.18% | +0.01 |
| Icici Prudential Pharma Healthcare And Diaganostics (P.H.D) Fund | DII | 3.13% | −1.42 |
| Clarus Capital I | DII | 2.16% | +0.21 |
| Bandhan Small Cap Fund | DII | 1.14% | +0.02 |
| Lata Jain | Promoter | 0.01% | 0.00 |
Promoters held 75.24% of Akums Drugs and Pharmaceuticals at the end of the Jun 2026 quarter, the same as a year earlier.
In the Jun 2026 quarter, foreign institutional investors (FIIs) held 1.92% (up 0.53 percentage points from 1.39% a quarter earlier) and domestic institutions (DIIs) held 13.41% (down 0.92 percentage points from 14.33% a quarter earlier).
No. The Jun 2026 filing shows no pledged promoter shares.
Akums Drugs and Pharmaceuticals had 70,290 shareholders at the end of the Jun 2026 quarter, against 69,425 a year earlier.
Franklin India Opportunites Fund (DII) held 4.18% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.